Outlook Therapeutics (OTLK) Current Taxes: 2015-2019
Historic Current Taxes for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $1.9 million.
- Outlook Therapeutics' Current Taxes rose 0.18% to $1.9 million in Q2 2020 from the same period last year, while for Jun 2020 it was $1.9 million, marking a year-over-year increase of 0.18%. This contributed to the annual value of $1.9 million for FY2019, which is 0.18% up from last year.
- As of FY2019, Outlook Therapeutics' Current Taxes stood at $1.9 million, which was up 0.18% from $1.9 million recorded in FY2018.
- Outlook Therapeutics' 5-year Current Taxes high stood at $2.4 million for FY2017, and its period low was $1.8 million during FY2015.
- Over the past 3 years, Outlook Therapeutics' median Current Taxes value was $1.9 million (recorded in 2019), while the average stood at $2.0 million.
- Per our database at Business Quant, Outlook Therapeutics' Current Taxes rose by 26.82% in 2017 and then dropped by 21.09% in 2018.
- Yearly analysis of 5 years shows Outlook Therapeutics' Current Taxes stood at $1.8 million in 2015, then rose by 5.70% to $1.9 million in 2016, then rose by 26.82% to $2.4 million in 2017, then declined by 21.09% to $1.9 million in 2018, then grew by 0.18% to $1.9 million in 2019.